Robert L. Barbieri, MD

Article

The clinical utility of newly approved angiogenic markers for identifying patients at risk for adverse outcomes due to preeclampsia

Author:: Robert L. Barbieri, MD

Publish date: December 11, 2023

Preeclampsia is one of the biggest clinical challenges in obstetric practice. A normal ratio of soluble fms-like tyro...

Article

Breakthroughs in the prevention of RSV disease among infants

Author:: Robert L. Barbieri, MD

Publish date: November 14, 2023

RSV disease is a major public health problem among infants younger than age 8 months, causing 100 to 300 deaths annually. In 2023, two ...

Article

Nonhormonal medication treatment of VMS

Author:: Robert L. Barbieri, MD

Publish date: October 11, 2023

For patients with bothersome vasomotor symptoms (VMS) who cannot or choose not to take estrogen, nonhormonal medication options include escitalopra...

Article

Medication treatment of opioid use disorder in primary care practice: Opportunities and limitations

Author:: Robert L. Barbieri, MD

Publish date: September 11, 2023

Restrictions on prescribing buprenorphine (BUP) for opioid use disorder (OUD) have been rescinded, increasing the opportunity for primary care clin...

Article

Intrauterine vacuum device treatment of postpartum hemorrhage

Author:: Robert L. Barbieri, MD

Publish date: August 15, 2023

First-line, conservative treatment of postpartum hemorrhage includes uterotonic medications and, if indicated, uterine balloon tamponade or intraut...

Article

Anti-obesity medications: Breakthroughs and limitations

Author:: Robert L. Barbieri, MD

Publish date: July 9, 2023

Semaglutide is a breakthrough, practice-changing weight loss medication that reliably causes significant weight loss; however, weight gain is commo...

Article

Therapeutic hypothermia to treat neonatal encephalopathy improves childhood outcomes

Author:: Robert L. Barbieri, MD

Publish date: June 7, 2023

Whole-body cooling, initiated within 6 hours of birth for a newborn with neonatal encephalopathy, improves childhood neurodevelopmental outcomes, b...

Article

Would you prescribe antenatal steroids to a pregnant patient at high risk for delivering at 22 weeks’ gestation?

Author:: Robert L. Barbieri, MD

Publish date: May 17, 2023

For infants born at 22 to 23 weeks’ gestation, the combination of a completed course of antenatal steroids plus active support of the newborn at bi...

Article

What is the most effective management of first trimester miscarriage?

Author:: Robert L. Barbieri, MD

Publish date: April 16, 2023

A Cochrane network meta-analysis reported that both uterine aspiration and medication management are more effective than expectant management for t...

Article

Advances in the treatment of fetal demise in the second and third trimester

Author:: Robert L. Barbieri, MD

Publish date: March 28, 2023

Treatment of fetal demise is best managed as a 2-step process, beginning with cervical preparation using cervical dil...

Article

Is it time to reconsider Rh testing and Rh D immune globulin treatment for miscarriage and abortion care in early pregnancy?

Author:: Robert L. Barbieri, MD

Publish date: February 19, 2023

New guidelines propose to reduce the use of Rh testing and Rh D immune globulin administration for miscarriage and abortion care in early pregnancy...